TABLE 2.
Antibiotic susceptibility profiles for prevalent and sporadic SALs
| Antibiotica | No. of isolates with indicated profile for SALb:
|
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (n = 17)
|
2 (n = 4)
|
4 (n = 8)
|
5 (n = 11)
|
6 (n = 10)
|
Sporadic (n = 12)
|
|||||||||||||
| S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | |
| Cefazolin | 17 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 7 | 11 | 0 | 0 | 9 | 0 | 1 | 11 | 0 | 1 |
| Ciprofloxacin | 14 | 2 | 1 | 4 | 0 | 0 | 2 | 0 | 6 | 10 | 1 | 0 | 10 | 0 | 0 | 11 | 0 | 1 |
| Clindamycin | 12 | 5 | 0 | 4 | 0 | 0 | 2 | 0 | 6 | 11 | 0 | 0 | ND | ND | ND | 5 | 4 | 3 |
| Erythromycin | 10 | 4 | 3 | 3 | 1 | 0 | 1 | 0 | 7 | 5 | 0 | 6 | 5 | 0 | 5 | 4 | 5 | 3 |
| Oxacillin | 17 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 8 | 8 | 3 | 0 | 8 | 1 | 1 | 10 | 0 | 2 |
| Penicillin | 2 | 0 | 15 | 0 | 0 | 4 | 0 | 0 | 8 | 2 | 0 | 9 | 0 | 0 | 10 | 2 | 0 | 10 |
| TMP-SXT | 15 | 1 | 1 | 4 | 0 | 0 | 6 | 0 | 2 | 11 | 0 | 0 | ND | ND | ND | 10 | 0 | 2 |
| Vancomycin | 17 | 0 | 0 | 4 | 0 | 0 | 8 | 0 | 0 | 11 | 0 | 0 | 10 | 0 | 0 | 12 | 0 | 0 |
a
Antibiotic susceptibilities were determined by the NCCLS disk diffusion method.
b
Abbreviations: S, susceptible; I, intermediate; R, resistant; ND, not determined.